Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients

Published:2024-03 Issue: Volume:130 Page:111640
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Zhaoyun,Shen Hongli,Han Mei,Zhao Xianghong,Liu Hui,Ding Kai,Song Jia,Fu Rong

Funder

National Natural Science Foundation of China National Outstanding Youth Science Fund Project

Tianjin Municipal Health Commission

China Postdoctoral Science Foundation

Tianjin Municipal Natural Science Foundation

TianJin Education Committee

Tianjin Science and Technology Program

Publisher

Elsevier BV

Reference36 articles.

1. Molecular pathogenesis of multiple myeloma and its premalignant precursor;Kuehl;Journal of Clinical Investigation.,2012

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;The Lancet. Oncology.,2014

3. Novel therapeutic strategies for multiple myeloma;Mimura;Exp Hematol.,2015

4. The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma;Rasche;Int J Mol Sci.,2019

5. Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma;Gupta;Blood.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP